BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32285484)

  • 1. Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy.
    Sotirchos ES; Gonzalez Caldito N; Filippatou A; Fitzgerald KC; Murphy OC; Lambe J; Nguyen J; Button J; Ogbuokiri E; Crainiceanu CM; Prince JL; Calabresi PA; Saidha S;
    Ann Neurol; 2020 Jun; 87(6):885-896. PubMed ID: 32285484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
    Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R
    PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS Trial.
    Ehrhardt H; Lambe J; Moussa H; Vasileiou ES; Kalaitzidis G; Murphy OC; Filippatou AG; Pellegrini N; Douglas M; Davis S; Nagy N; Quiroga A; Hu C; Zambriczki Lee A; Duval A; Fitzgerald KC; Prince JL; Calabresi PA; Sotirchos ES; Bermel R; Saidha S
    Neurology; 2023 Sep; 101(10):e1014-e1024. PubMed ID: 37460235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis.
    Cellerino M; Priano L; Bruschi N; Boffa G; Petracca M; Novi G; Lapucci C; Sbragia E; Uccelli A; Inglese M
    J Neuroophthalmol; 2021 Sep; 41(3):329-334. PubMed ID: 33399416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
    Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
    Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
    Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
    Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
    Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
    Lambe J; Risher H; Filippatou AG; Murphy OC; Sotirchos ES; Ehrhardt H; Ogbuokiri E; Pellegrini N; Toliver B; Luciano NJ; Davis S; Fioravante N; Kwakyi O; Prince JL; Calabresi PA; Fitzgerald KC; Saidha S
    Neurology; 2021 May; 96(20):e2525-e2533. PubMed ID: 33827962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.
    Miscioscia A; Puthenparampil M; Miante S; Pengo M; Rinaldi F; Perini P; Gallo P
    J Neurol; 2022 Oct; 269(10):5436-5442. PubMed ID: 35648233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple Sclerosis.
    El Ayoubi NK; Sabbagh HM; Bou Rjeily N; Hannoun S; Khoury SJ
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36229190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.
    González-López JJ; Rebolleda G; Leal M; Oblanca N; Muñoz-Negrete FJ; Costa-Frossard L; Alvarez-Cermeño JC
    Biomed Res Int; 2014; 2014():128517. PubMed ID: 25313352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroid plexus volume as a marker of retinal atrophy in relapsing remitting multiple sclerosis.
    Raghib MF; Bao F; Elkhooly M; Bernitsas E
    J Neurol Sci; 2024 Feb; 457():122884. PubMed ID: 38237367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
    Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
    Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study.
    Paul F; Calabresi PA; Barkhof F; Green AJ; Kardon R; Sastre-Garriga J; Schippling S; Vermersch P; Saidha S; Gerendas BS; Schmidt-Erfurth U; Agoropoulou C; Zhang Y; Seifer G; Petzold A
    Ann Clin Transl Neurol; 2021 Dec; 8(12):2235-2251. PubMed ID: 34792863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.
    Button J; Al-Louzi O; Lang A; Bhargava P; Newsome SD; Frohman T; Balcer LJ; Frohman EM; Prince J; Calabresi PA; Saidha S
    Neurology; 2017 Feb; 88(6):525-532. PubMed ID: 28077493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis.
    Knier B; Leppenetier G; Wetzlmair C; Aly L; Hoshi MM; Pernpeintner V; Biberacher V; Berthele A; Mühlau M; Zimmer C; Hemmer B; Korn T
    JAMA Neurol; 2017 Jul; 74(7):847-856. PubMed ID: 28460032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal nerve fiber and ganglion cell complex layer thicknesses mirror brain atrophy in patients with relapsing-remitting multiple sclerosis.
    Glasner P; Sabisz A; Chylińska M; Komendziński J; Wyszomirski A; Karaszewski B
    Restor Neurol Neurosci; 2022; 40(1):35-42. PubMed ID: 35180139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal imaging and axonal degeneration in later onset multiple sclerosis.
    Huhn K; Lämmer R; Zimmermann H; Lämmer A; Waschbisch A; Utz K; Gieß RM; Paul F; Linker RA; Lee DH
    J Neurol Sci; 2016 Nov; 370():1-6. PubMed ID: 27772735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
    Petracca M; Cordano C; Cellerino M; Button J; Krieger S; Vancea R; Ghassemi R; Farrell C; Miller A; Calabresi PA; Lublin F; Inglese M
    Mult Scler; 2017 Jan; 23(1):43-50. PubMed ID: 26993116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Optical Coherence Tomography Markers for Multiple Sclerosis Diagnosis and Management.
    Cujba L; Stan C; Samoila O; Drugan T; Benedec Cutas A; Nicula C
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.